ArticleJournal for immunotherapy of cancer2024

Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.

Florian Hornsteiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.